Document is current
Any future updates will be listed below
-
Authors
Martin, K. https://orcid.org/0000-0001-9176-2497
Geuens, S.
Asche, J. K.
Bodan, R.
Browne, F.
Downe, A.
García García, N.
Jaega, G.
Kennedy, B.
Mauritz, P. J.
Pérez, F.
Soon, K.
Zmazek, V.
Mayre-Chilton, K. M.
-
Funding
Funding for this research was provided by:
Debra International (NA)
DEBRA Norge (NA)
- License Information
-
More Information
Article History
Received: 11 December 2018
Accepted: 1 May 2019
First Online: 11 June 2019
Authors’ information
: Additional file
: Not applicable.
: Not applicable.
: Two authors declared potential CoI with respect to this guideline: they were associates to DEBRA Norway and DI executive team; guideline Coordinator for DI and project manager of this CPG. These authors were therefore not involved in the final recommendation manuscript editions post review panel feedback. Two reviewers declared a CoI; one reported to “hold to different operating frameworks and assumptions as well as professional competitors and rivals in a pool of diminishing mental health resources”; for the other, the guidelines directly relate to their work, PhD and research. The CoI were reviewed by the Chairs and DI CPG coordinator and were considered not to influence the recommendations. No one involved in the guideline has any connection to manufacturers within the field of EB or medical pharmaceuticals.Please see Additional file .
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
